Investorideas.com newswire, breaking biotechnology and pharma news

Monday, August 12, 2024

Oragenics, Inc. (NYSE American: OGEN) Gains on News of Completing FDA-Required Genotoxicity Study

Oragenics, Inc. (NYSE American: OGEN) Gains on News of Completing FDA-Required Genotoxicity Study: Oragenics, Inc. (NYSE American: OGEN) Gains on News of Completing FDA-Required Genotoxicity Study

No comments:

Post a Comment